- Title
- Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia
- Creators
- Francis Giles - HRB Clinical Research Facility, National University of Ireland Galway and Trinity College Dublin, Dublin, IrelandFrançois-Xavier Mahon - Université Bordeaux Ségalen, INSERM U1035, Institut Bergonié, Centre Hospitalier universitaire, Bordeaux, FranceBjorn Gjertsen - Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, NorwayRonan Swords - Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USABoris Labar - Clinical Hospital Center and School of Medicine, University of Zagreb, Zagreb, CroatiaAnna Turkina - Hematology Research Center, Moscow, Russian FederationGianantonio Rosti - Department of Hematology and Oncology 'Seragnoli', Bologna University Hospital, Bologna, Italy
- Publication Details
- European journal of clinical investigation, Vol.42(9), pp.1016-1026
- Publisher
- Blackwell Publishing Ltd
- Edition
- Received 20 December 2011; accepted 20 March 2012
- Number of pages
- 11
- Language
- English
- Resource Type
- Journal article
- PMID
- 22548456
- Record Identifier
- 991031613373502976
Journal article
Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia
European journal of clinical investigation, Vol.42(9), pp.1016-1026
Received 20 December 2011; accepted 20 March 2012
2012-09
PMID: 22548456
Metrics
6 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.103 Blood Disorders
- 1.103.1126 Chronic Myeloid Leukemia
- Web Of Science research areas
- Medicine, Research & Experimental
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites